4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-001348
PRESIDENT AND COO sold 10,000 shares at an average $371.05 ($3,710,499)
- PRESIDENT AND COO acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,500 | $111.00 | $832,500 | 7,500 | I |
| 2025-02-18 | Sale : show line 2 in the form 10b5-1 | −100 | $366.19 | $36,619 | 7,400 | I |
| 2025-02-18 | Sale : show line 3 in the form 10b5-1 | −600 | $368.32 | $220,994 | 6,800 | I |
| 2025-02-18 | Sale : show line 4 in the form 10b5-1 | −1,432 | $369.65 | $529,343 | 5,368 | I |
| 2025-02-18 | Sale : show line 5 in the form 10b5-1 | −1,068 | $370.70 | $395,911 | 4,300 | I |
| 2025-02-18 | Sale : show line 6 in the form 10b5-1 | −2,351 | $371.47 | $873,318 | 1,949 | I |
| 2025-02-18 | Sale : show line 7 in the form 10b5-1 | −1,549 | $372.63 | $577,196 | 400 | I |
| 2025-02-18 | Sale : show line 8 in the form 10b5-1 | −400 | $373.67 | $149,469 | 0 | I |
| Open-market sales · 10,000 sh · avg $371.05 · $3,710,499 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −7,500 | $111.00 | 2028-03-15 | 7,500 | 14,679 | I |
| 2025-02-18 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Options | −2,500 | $111.00 | 2028-03-15 | 2,500 | 7,000 | I |
Loading xslF345X05/primarydocument.xml…